Fujifilm Holdings America Corporation has opened its new Fujifilm Life Science Strategic Business Office located at One Kendall Square in Cambridge, MA. The new office creates a strategic presence that will facilitate Fujifilm to cultivate and foster relationships with pharmaceutical and biotechnology businesses, and the technology communities in the surrounding area.   
 
Over the past decade, Fujifilm Corporation has focused its efforts and investments across the areas of cell and gene therapeutics, biopharmaceutical contract development and manufacturing, cell culture media and reagents, research-use tools and instruments, in-vitro diagnostics, drug discovery and drug delivery solutions.
 
“Our goal is to connect, invest and co-innovate with academic, institutional, commercial and government partners with the overall objectives to accelerate translational medicine, and improve patient care and quality of life,” said Yutaka Yamaguchi, president and chief executive officer, Fujifilm Irvine Scientific Inc., and also general manager of the new Fujifilm Life Science Strategic Business Office.
 
“Over the past few years, Fujifilm has made significant investments in the life science business including sponsored research, licensing, business partnerships and acquisitions,” said Bruce Novich, division president, corporate new business development division, Fujifilm Holdings America Corporation. “Our new location in Cambridge provides an ideal environment to foster collaboration and bring business and technology together.”